Antimicrobial Susceptibility Pattern and Serotype Distribution of Streptococcus Pneumoniae in the Middle East Region: A Systematic Review and Meta-Analysis
Abstract
This study aimed to explore the prevalence, antimicrobial resistance levels, and serotype distribution of S. pneumoniae in the Middle East region. We conducted a systematic literature review by searching several databases including PubMed, ISI Web of Science, Scopus, Google scholar through 2000 to 2017 by using the following keywords: “Streptococcus pneumoniae”, “pneumococcus”, “serotype”, “Antibiotic resistance,” and “Middle East “in combination with “OR” and “AND” Boolean Operators within Title/Abstract/Keywords fields. We used a random-effects model to calculate the pooled prevalence and 95% confidence intervals (CIs) for binomial variables. All statistical analyses were done using STATA 12.0 (STATA Corp, College Station, TX). We found 73 articles appropriate, on the word of inclusion and exclusion criteria, for inclusion in this systematic review and meta-analysis. The result revealed that the pooled prevalence of S. pneumoniae carriage was 35% (95% CI: 26-44%). The most frequent pneumococcal serotypes were19, 19F, 6, 23 and 6A/B which were found in 19%,12%, 11%, 10% and 10% of isolates respectively. Pneumococcal resistance reported for azithromycin, cefaclor, clarithromycin, chloramphenicol, erythromycin, and tetracycline were 24%, 37%, 23%, 11%, 26%, and 29% respectively, while vancomycin resistance was not reported. The highest resistant prevalence was reported against co-trimoxazole (Trimethoprim/sulfamethoxazole). For this antibiotic, a pooled resistance prevalence of 43% was identified. The present review demonstrates that the prevalence of S. pneumoniae carriage was high in the Middle East region. Surveillance must be continued in this region to evaluate. The resistance pattern and serotype distribution.
2. Al-Sherikh Y, K Gowda L, Ali M, Marie M, John J, Khaled Homoud Mohammed D, et al. distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia. Ann Lab Med 2014;34:210-5.
3. Habibian S, Mehrabi-Tavana A, Ahmadi Z, Izadi M, Jonaidi N, Darakhshanpoure J, et al. Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. Iran Red Crescent Med J 2013;15:e8053.
4. Jaiswal N, Singh M, Das RR, Jindal I, Agarwal A, Thumburu KK, et al. distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review. PloS one 2014;9:e108617.
5. Mahboobi R, Afshar D, Pourmand MR, and Mashhadi R. Autolytic activity and plasma binding study of Aap, a novel minor autolysin of Streptococcus pneumoniae. Acta Med Iran 2016;54:196-200.
6. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008;6:288-301.
7. Institute JB. The Joanna Briggs Institute Reviewers’ Manual 2014 edition. Adelaide: JBI, 2014.
8. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 2014;72:39.
9. Ahmadi A, Talebi M, Irajian G. High Prevalence of Erythromycin-and Tetracycline-Resistant Clinical Isolates of Streptococcus pneumoniae in Iran. Infect Dis Clin Pract 2013;21:299-301.
10. Ahmed K, Martinez G, Wilson S, Yoshida R, Dhar R, Mokaddas E, et al. The prevalence and clonal diversity of penicillin-resistant Streptococcus pneumoniae in Kuwait. Epidemiol Infect 2000;125:573-81.
11. Aliskan HE, Colakoglu S, Gocmen JS. Antibiotic resistance of streptococcus pneumoniae and haemophilus influenzae isolated from respiratory tract specimens. Cukurova Med J 2016;41:201-7.
12. Al-Mazrou A, Twum-Danso K, Al Zamil F. Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines. Ann Saudi Med 2005;25:94-9.
13. Alnimr AM, Farhat M. Phenotypic and molecular study of pneumococci causing respiratory tract infections A 3-year prospective cohort. Saudi Med J 2017;38:350-8.
14. Al-Swailem AM, Kadry AA, Fouda SI, Shibl AM, Shair OH. Phenotypic and genotypic characterization of invasive Streptococcus pneumoniae clinical isolates. Curr Ther Res Clin Exp 2004;65:423-32.
15. Al-Tawfiq JA. Pattern of antibiotic resistance of Streptococcus pneumoniae in a hospital in the Eastern Province of Saudi Arabia. J Chemother 2004;16:259-63.
16. Al-Tawfiq JA. Antibiotic resistance of pediatric isolates of Streptococcus pneumoniae in a Saudi Arabian hospital from 1999 to 2004. Med Sci Monit 2006;12:CR471-5.
17. Altinkanat Gelmez G, Soysal A, Kuzdan C, Karadag B, Hasdemir U, Bakir M, et al. [Serotype distribution and antibiotic susceptibilities of Streptococcus pneumoniae causing acute exacerbations and pneumonia in children with chronic respiratory diseases]. Mikrobiyol Bul 2013;47:684-92.
18. Altun B, Gur D, Kocagoz S, Hascelik G, Unal S. Molecular epidemiology of penicillin resistant Streptococcus pneumoniae strains in Turkey. A multicenter study. Ann Microbiol 2006;56:185-90.
19. Altun HU, Hascelik G, Gur D, Eser OK. Invasive pneumococci before the introduction of pneumococcal conjugate vaccine in Turkey: antimicrobial susceptibility, serotype distribution, and molecular identification of macrolide resistance. J Chemother 2015;27:74-9.
20. Ashtiani MTH, Sadeghian M, Nikmanesh B, Pourakbari B, Mahmoudi S, Mamishi S. Antimicrobial susceptibility trends among Streptococcus pneumoniae over an 11-year period in an Iranian referral children Hospital. Iran J Microbiol 2014;6:382-6.
21. Aslan G, Ernekdas G, Bayer M, Serin MS, Kuyucu N, Kanik A. Serotype distribution of Streptococcus pneumoniae strains in the nasopharynx of healthy Turkish children. Indian J Med Res 2007;125:582-7.
22. Aslan G, Tezcan S, Delialioglu N, Aydin FE, Kuyucu N, Emekdas G. [Evaluation of penicillin-binding protein genotypes in penicillin susceptible and resistant Streptococcus pneumoniae isolates]. Mikrobiyol Bul 2012;46:190-201.
23. Ataee RA, Habibian S, Mehrabi-Tavana A, Ahmadi Z, Jonaidi N, Salesi M. Determination of vancomycin minimum inhibitory concentration for ceftazidime resistant Streptococcus pneumoniae in Iran. Ann Clin Microbiol Antimicrob 2014;13:53.
24. Bahy RH, Hamouda HM, Shahat AS, Yassin AS, Amin MA. Emergence of Neoteric Serotypes Among Multidrug Resistant Strains of Streptococcus pneumoniae Prevalent in Egypt. Jundishapur J Microbiol 2016;9:e30708.
25. Bayer M, Aslan G, Emekdas G, Kuyucu N, Kanik A. [Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children and multidrug resistance]. Mikrobiyol Bul 2008;42:223-30.
26. Bayraktar MR, Durmaz B, Kalcioglu MT, Durmaz R, Cizmeci Z, Aktas E. Nasopharyngeal carriage, antimicrobial susceptibility, serotype distribution and clonal relatedness of Streptococcus pneumoniae isolates in healthy children in Malatya, Turkey. Int J Antimicrob Agents 2005;26:241-6.
27. Bokaeian M, Khazaei HA, Javadimehr M. Nasopharyngeal Carriage, Antibiotic Resistance and Serotype Distribution of Streptococcus Pneumoniae among Healthy Adolescents in Zahedan. Iran Red Crescent Med J 2011;13:328-33.
28. Bokaeian M, Khazaei HA, Javadimehr M. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates from children in Zahedan, Iran. African J Microbiol Res 2012;6:28-33.
29. Ceyhan M, Ozsurekci Y, Gurler N, Ozkan S, Sensoy G, Belet N, et al. Distribution of Streptococcus pneumoniae Serotypes That Cause Parapneumonic Empyema in Turkey. Clin Vaccine Immunol 2013;20:972-6.
30. Ciftci E, Dogru U, Aysev D, Ince E, Guriz H. Nasopharyngeal colonization with penicillin-resistant Streptococcus pneumoniae in Turkish children. Pediatr Int 2000;42:552-6.
31. Dabboussi F, Allouche S, Mallat H, Hamze M. Prevalence of first-step mutants among levofloxacin-susceptible isolates of Streptococcus pneumoniae in north Lebanon. J Chemother 2013;25:328-31.
32. Daoud Z, Cocozaki A, Hakime N. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004. Clin Microbiol Infect 2006;12:86-90.
33. Daoud Z, Kourani M, Saab R, Nader MA, Hajjar M. Resistance of Streptococcus pneumoniae isolated from Lebanese patients between 2005 and 2009. Rev Esp Quimioter 2011;24:84-90.
34. Dashti AS, Abdinia B, Karimi A. Nasopharyngeal carrier rate of Streptococcus pneumoniae in children: serotype distribution and antimicrobial resistance. Arch Iran Med 2012;15:500-3.
35. Elshafie S, Taj-Aldeen SJ. Emerging resistant serotypes of invasive Streptococcus pneumoniae. Infect Drug Resist 2016;9:153-60.
36. Eltahawy AT. Antimicrobial resistance of Streptococcus pneumoniae at a university hospital in Saudi Arabia. J Chemother 2001;13:148-53.
37. Esel D, Sumerkan B, Kocagoz S. Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in Kayseri, Turkey. Clin Microbiol Infect 2001;7:548-52.
38. Fouda S, Kadry A, Shibl A. β-lactam and macrolide resistance and serotype distribution among Streptococcus pneumoniae isolates from Saudi Arabia. J Chemother 2004;16:517-23.
39. Gonullu N, Berkiten R. Antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Istanbul. Int J Antimicrob Agents 2000;16:77-8.
40. Gonullu N, Catal F, Kucukbasmaci O, Ozdemir S, Torun MM, Berkiten R. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey. Chemotherapy 2009;55:161-7.
41. Guldemir D, Acar S, Otgun SN, Unaldi O, Gozalan A, Ertek M, et al. High-Level Genetic Diversity among Invasive Streptococcus pneumoniae Isolates in Turkey. Japanese Journal of Infectious Diseases. 2016;69:207-12.
42. Gur D, Guciz B, Hascelik G, Esel D, Sumerkan B, Over U, et al. Streptococcus pneumoniae penicillin resistance in Turkey. J Chemother 2001;13:541-5.
43. Gur D, Mulazimoglu L, Unal S. In vitro susceptibility of respiratory isolates of streptococcus pneumoniae and streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of E-Baskett-II Surveillance Study. Mikrobiyol Bul 2007;41:1-9.
44. Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, et al. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon. Vaccine 2012;30:G11-7.
45. Houri H, Karimi A, Saee Y, Fallah F, Rahbar M, Tabatabaei SR. Distribution of capsular types and drug resistance patterns of invasive pediatric Streptococcus pneumoniae isolates in Teheran, Iran. Int J Infect Dis 2017;57:21-6.
46. Ilki A, Sairoglu P, Elgormus N, Soyletir G. Trends in Antibiotic Susceptibility Patterns of Streptococcus Pneumoniae and Haemophilus Influenzae Isolates: Four Years Follow Up. Mikrobiyol Bul 2010;44:169-75.
47. Imani R, Rouhi H, Ganji F. Prevalence of antibiotic resistance among bacteria isolates of lower respiratory tract infection in COPD Shahrekord Iran, 2005. Pakistan J Med Sci 2007;23:438-40.
48. Karam Sarkis D, Hajj A, Adaime A. [Evolution of the antibiotic resistance of Streptococcus pneumoniae from 1997 to 2004 at Hotel-Dieu de France, a university hospital in Lebanon]. Pathol Biol (Paris) 2006;54:591-5.
49. Kargar M, Baghernejad M, Ghorbani-Dalini S, Najafi A. Multi-drug resistance and molecular pattern of erythromycin and penicillin resistance genes in Streptococcus pneumoniae. African J Biotechnol 2012;11:968-73.
50. Keles E, Aral M, Alpay HC. Antibiotic sensitivities of Streptococcus pneumoniae, viridans streptococci, and group A hemolytic streptococci isolated from the maxillary and ethmoid sinuses. Kulak Burun Bogaz Ihtis Derg 2006;16:18-24.
51. Kohanteb J, Sadeghi E. Penicillin-resistant Streptococcus pneumoniae in Iran. Med Princ Pract 2007;16:29-33.
52. Krishnappa LG, Marie MA, John J, Dabwan KH, Shashidhar PC. Serological and molecular capsular typing, antibiotic susceptibility of Streptococcus pneumoniae isolates from invasive and non-invasive infections. Acta Microbiol Immunol Hung 2014;61:173-9.
53. Memish ZA, Alkhy HHB, Shibl AA, Barrozo CP, Gray GC. Streptococcus pneumoniae in Saudi Arabia: antibiotic resistance and serotypes of recent clinical isolates. Int J Antimicrob Agents 2004;23:32-8.
54. Mirzaei Ghazi Kalayeh H, Moniri R, Moosavi SGA, Rezaei M, Yasini M, Valipour M. Serotyping, Antibiotic Susceptibility and Related Risk Factors Aspects of Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy School Students. Iran J Public Health 2014;43:1284-90.
55. Mokaddas EM, Rotimi VO, Albert MJ. Increasing prevalence of antimicrobial resistance in Streptococcus pneumoniae in Kuwait: Implications for therapy. Microb Drug Resist 2007;13:227-33.
56. Mokaddas EM, Rotimi VO, Albert MJ. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol 2008;15:203-7.
57. Mokaddas EM, Wilson S, Sanyal SC. Prevalence of penicillin-resistant Streptococcus pneumoniae in Kuwait. J Chemother 2001;13:154-60.
58. Mosleh MN, Gharibi M, Alikhani MY, Saidijam M, Vakhshiteh F. Antimicrobial susceptibility and analysis of macrolide resistance genes in Streptococcus pneumoniae isolated in Hamadan. Iran J Basic Med Sci 2014;17:595-9.
59. Nasereddin A, Shtayeh I, Ramlawi A, Salman N, Salem I, Abdeen Z. Streptococcus pneumoniae from Palestinian Nasopharyngeal Carriers: Serotype Distribution and Antimicrobial Resistance. Plos One 2013;8:e82047.
60. Oguzkaya Artan M, Baykan Z, Artan C. Antimicrobial susceptibility of Streptococcus pneumoniae in the oropharynx of healthy preschool children and identification of risk factors. Jpn J Infect Dis.2008;61:302-3.
61. Oskoui M, Feyzabadi M, Amirkhani A. Drug susceptibility of Streptococcus pneumoniae strains isolated in Tehran, Iran. Archives of Iranian medicine 2003;6:192-5.
62. Ozakin C, Guler H, Gurcuoglu E, Ozbey SB, Kazak E, Sinirtas AM. A study on molecular characterization of macrolide resistance mechanism among isolates of Streptococcus pneumoniae from the southern Marmara region of Turkey, as well as resistance to macrolides and penicillin in these isolates. Turkish J Med Sci 2012;42:137-44.
63. Ozalp M, Kanra G, Gur D. Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae in a children's hospital in Turkey. Turkish J Pediatr 2004;46:329-32.
64. Sener B, Tunckanat F, Ulusoy S, Tunger A, Soyletir G, Mulazimoglu L, et al. A survey of antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae in Turkey, 2004 2005. J Antimicrob Chemother 2007;60:587-93.
65. Senok A, Al-Zarouni M, Al-Najjar J, Nublusi A, Panigrahi D. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006. J Infect Dev Ctries 2007;1:296-302.
66. Shibl AM. Patterns of macrolide resistance determinants among S-pyogenes and S-pneumoniae isolates in Saudi Arabia. J Int Med Res 2005;33:349-55.
67. Shibl AM, Al Rasheed AM, Elbashier AM, Osoba AO. Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia. J Chemother 2000;12:134-7.
68. Swedan SF, Hayajneh WA, Bshara GN. Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier children. Indian J Med Microbiol 2016;34:159-65.
69. Taha N, Araj GF, Wakim RH, Kanj SS, Kanafani ZA, Sabra A, et al. Genotypes and serotype distribution of macrolide resistant invasive and non-invasive Streptococcus pneumoniae isolates from Lebanon. Ann Clin Microbiol Antimicrob 2012;11:2.
70. Tavana AM, Ataee RA, Esmaili D. Serotyping Distribution of Invasive Pneumococcal Disease (IPD) in Iranian Patients. J Pure Appl Microbiol 2012;6:155-60.
71. Telli M, Eyigor M, Gultekin B, Aydin N. Evaluation of resistance mechanisms and serotype and genotype distributions of macrolide-resistant strains in clinical isolates of Streptococcus pneumonia in Aydin, Turkey. Journal of Infection and Chemotherapy. 2011;17:658-64.
72. Twum-Danso K, Al-Mazrou AM, Al-Zamil FA. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia. Saudi Med J 2003;24:1210-3.
73. Uncu H, Colakoglu S, Turunc T, Demiroglu YZ, Arslan H. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy]. Mikrobiyol Bul 2007;41:441-6.
74. Uwaydah M, Mokhbat JE, Karam-Sarkis D, Baroud-Nassif R, Rohban T. Penicillin-resistant Streptococcus pneumoniae in Lebanon: the first nationwide study. Int J Antimicrob Agents 2006;27:242-6.
75. Uzuner A, Ilki A, Akman M, Gundogdu E, Erbolukbas R, Kokacya O, et al. Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae in healthy children. Turk J Pediatr 2007;49:370-8.
76. Yalcin I, Gurler N, Alhan E, Yaman A, Turgut M, Celik U, et al. Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae disease isolates from children in Turkey, 2001-2004. Eur J Pediatr 2006;165:654-7.
77. Yenisehirli G, Sener B. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty]. Mikrobiyol Bul 2003;37:1-11.
78. Yurdakul AS, Calisir HC, Atasever M, Ordulu L, Ogretensoy M. Resistance to penicillin among the Streptococcus pneumoniae in Turkey. Eur Respir J 2001;18:436.
79. Adegbola RA, DeAntonio R, Hill PC, Roca A, Usuf E, Hoet B, et al. Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis. PLoS One 2014;9:e103293.
80. Usuf E, Bottomley C, Adegbola RA, Hall A. Pneumococcal carriage in sub-Saharan Africa--a systematic review. PLoS One 2014;9:e85001.
81. Zivich PN, Grabenstein JD, Becker-Dreps SI, Weber DJ. Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review. Pneumonia (Nathan) 2018;10:11.
82. Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, et al. Pneumococcal Capsules and Their Types: Past, Present, and Future. Clin Microbiol Rev 2015;28:871-99.
83. Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine 2012;30:3503-14.
84. Cherazard R, Epstein M, Doan TL, Salim T, Bharti S, Smith MA. Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications. Am J Ther 2017;24:e361-e9.
85. Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zeng J, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis 2017;17:804.
86. Kawaguchiya M, Urushibara N, Aung MS, Morimoto S, Ito M, Kudo K, et al. Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan. New Microbes New Infect 2016;9:66-72.
87. El Moujaber G, Osman M, Rafei R, Dabboussi F, Hamze M. Molecular mechanisms and epidemiology of resistance in Streptococcus pneumoniae in the Middle East region. J Med Microbiol 2017;66:847-58.
Files | ||
Issue | Vol 59, No 2 (2021) | |
Section | Review Article(s) | |
DOI | https://doi.org/10.18502/acta.v59i2.5572 | |
Keywords | ||
Streptococcus pneumoniae Antimicrobial susceptibility Serotype Middle east |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |